9 results on '"Nentwich MM"'
Search Results
2. [Optic Disk Drusen: Historical and Up-To-Date Aspects].
- Author
-
Nentwich MM, Maertz J, and Rudolph G
- Subjects
- Diagnosis, Differential, Eye Proteins genetics, Genetic Markers genetics, Genetic Predisposition to Disease genetics, Humans, Optic Disk Drusen therapy, Optic Disk Drusen diagnosis, Optic Disk Drusen genetics, Retinal Diseases diagnosis, Retinal Diseases genetics, Retinal Diseases therapy
- Abstract
Optic disc drusen are an important differential diagnosis in the diagnostic evaluation of a prominent optic nerve head. Drusen of the optic disc occur in 0.34 to 2.4 % of human individuals and manifest themselves bilaterally in three of four cases. Drusen are found six times more often within histological sections than on funduscopic examination. It is known that optic disc drusen can occur in familial clusters without any other pathological ophthalmic findings. They can also be associated with retinitis pigmentosa, or with the Joubert or Alagille syndromes. Non-invasive diagnostic tools include fundus-autofluorescence (AF), optical coherence tomography (OCT) and ultrasound. Drusen of the optic nerve head are asymptomatic in most cases, though transient ischemia can lead to transient visual impairment. In particular, superficial drusen can lead to profound visual field defects in adulthood. Regular ophthalmological follow-up examinations with tonometry and perimetry are recommended for the early detection of visual field defects. Radial optic neurotomy (RON) seems to be a therapeutic option in patients with acute deterioration of the visual field., (Georg Thieme Verlag KG Stuttgart · New York.)
- Published
- 2016
- Full Text
- View/download PDF
3. [Congenital cranial dysinnervation disorders (CCDD)].
- Author
-
Nentwich MM, Nentwich MF, Maertz J, Brandlhuber U, and Rudolph G
- Subjects
- Eye Diseases, Hereditary diagnosis, Eye Diseases, Hereditary genetics, Fibrosis, Genetic Markers genetics, Humans, Ophthalmoplegia, Polymorphism, Single Nucleotide genetics, Genetic Predisposition to Disease genetics, Genetic Testing methods, Models, Genetic, Molecular Diagnostic Techniques methods
- Abstract
Knowledge about hereditary eye diseases has been substantially increased by means of genetic testing during the last decade. This has resulted in a new classification of a number of disease patterns, which are characterised by non-progressive restrictive disorders of the oculomotor system, formerly classified as "congenital fibrosis syndromes". Based on the results of genetic testing, these ocular motility disorders are now referred to as "congenital cranial dysinnervation disorders" (CCDDs). They are caused by an impaired innervation of extraocular muscles because of a dysgenesis of the nuclei of the affected cranial nerves in the brainstem and pons and not by primary fibrosis of the extraocular muscles. In this review, congenital fibrosis of the extraocular muscles (CFEOM), Duane syndrome, horizontal gaze palsy with progressive scoliosis, congenital ptosis and Moebius syndrome are presented and basic principles of intracellular transport mechanisms and kinesins are discussed., (Georg Thieme Verlag KG Stuttgart · New York.)
- Published
- 2015
- Full Text
- View/download PDF
4. [Genotype-phenotype correlation in patients with PRPH2-mutations].
- Author
-
Maertz J, Gloeckle N, Nentwich MM, and Rudolph G
- Subjects
- Adult, Female, Genetic Markers genetics, Genotype, Humans, Male, Middle Aged, Mutation genetics, Polymorphism, Single Nucleotide genetics, Statistics as Topic, Genetic Predisposition to Disease genetics, Genetic Testing methods, Macular Degeneration diagnosis, Macular Degeneration genetics, Peripherins genetics
- Abstract
Background: The peripherin-2 (PRPH2) gene encodes a photoreceptor-specific transmembrane-protein called peripherin-2 which is critical for the formation and maintenance of rod and cone outer segments. Over 90 different disease-causing mutations in PRPH2 have been identified which cause a variety of forms of macular degeneration and also retinopathia pigmentosa., Patients/material and Methods: This study is a retrospective observational study of 3 patients ascertained over a 5 month period in the ophthalmogenetic consultation of the university ophthalmic clinic. So far, the patients were followed for 8 months at least. Data examined included clinical history, pedigree analysis, ophthalmological examination, fundus photography, autofluorescence imaging, optical coherence tomography, Arden colour test, Goldmann perimetry and detailed electrophysiological assessment. Blood samples were taken for DNA extraction and mutation analysis of PRPH2 and ABCA4, BEST1, C1QTNF5, CDH3, CNGB3, ELOVL4, FSCN2, PROM1, RDH12, RP1L1, RPGR, TIMP3 was performed., Results: All patients had presented with clinically evident maculopathy and visual acuities in the range of 1/50 Metervisus to 0.8 p [dec.]. All had specific electroretinogrammes. All PRPH2 mutations were autosomal dominant. One family was heterozygous for a previously reported missense mutation in the PRPH2 gene c.514C>T, p.R172W. The other patient was heterozygous for a so far non-described PRPH2 deletion and frameshift mutation c.74_77delGGTT, p.W25SfsX12 leading most likely to a truncated, dysfunctional protein. All patients showed a significant, inter-individual phenotypical variability., Conclusion: The data add to the documented phenotypical variability of PRPH2 mutations and describe the c.74_77delGGTT, p.W25SfsX12 mutation within PRPH2 for the first time. FAF, OCT and electrophysiological exams are helpful tools for diagnosis and evaluation of macular disease due to PRPH2 mutations., (Georg Thieme Verlag KG Stuttgart · New York.)
- Published
- 2015
- Full Text
- View/download PDF
5. [Paracentral retinal changes].
- Author
-
Nentwich MM and Ulbig M
- Subjects
- Central Serous Chorioretinopathy complications, Combined Modality Therapy, Diagnosis, Differential, Humans, Male, Middle Aged, Mineralocorticoid Receptor Antagonists therapeutic use, Retinitis Pigmentosa diagnosis, Retinitis Pigmentosa therapy, Strabismus etiology, Tomography, Optical Coherence, Central Serous Chorioretinopathy diagnosis, Central Serous Chorioretinopathy therapy, Photochemotherapy, Spironolactone therapeutic use, Strabismus diagnosis, Strabismus therapy
- Published
- 2013
- Full Text
- View/download PDF
6. [Intraocular tumors in adults: uveal melanoma].
- Author
-
Mueller AJ, Schaller UC, Klingenstein A, and Nentwich MM
- Subjects
- Adult, Humans, Melanoma diagnosis, Melanoma therapy, Uveal Neoplasms diagnosis, Uveal Neoplasms therapy
- Published
- 2010
- Full Text
- View/download PDF
7. [Update: diagnosis and therapy of tropical diseases -- part 2].
- Author
-
Nentwich MM, Schaller UC, and Klauss V
- Subjects
- Humans, Eye Diseases diagnosis, Eye Diseases therapy, Tropical Climate, Tropical Medicine methods, Tropical Medicine trends
- Published
- 2009
- Full Text
- View/download PDF
8. [Update: diagnosis and therapy of tropical diseases - part 1].
- Author
-
Nentwich MM, Schaller UC, and Klauss V
- Subjects
- Humans, Eye Infections diagnosis, Eye Infections therapy, Ophthalmology trends, Tropical Climate, Tropical Medicine trends
- Published
- 2009
- Full Text
- View/download PDF
9. [Chronic endogenous endophthalmitis].
- Author
-
Nentwich MM, Kampik A, and de Kaspar HM
- Subjects
- Endophthalmitis complications, Eye Infections, Bacterial complications, Humans, Vision Disorders etiology, Anti-Bacterial Agents therapeutic use, Endophthalmitis diagnosis, Endophthalmitis drug therapy, Eye Infections, Bacterial diagnosis, Eye Infections, Bacterial drug therapy, Vision Disorders diagnosis, Vision Disorders prevention & control
- Abstract
An endogenous endophthalmitis is a severe, potentially blinding intraocular infection due to haematogenous spread of germs. In Europe, gram-positive bacteria and Candida albicans are common causative organisms. Compared to post-operative cases of endophthalmitis, endogenous endophthalmitis is relatively rare, accounting for 2-8% of all endophthalmitis cases. Most patients suffer from an underlying disease causing some kind of immunodeficiency. Other predisposing factors are long-term therapy in intensive-care units (ICU), intravenous catheters, iatrogenic immunosuppression or intravenous drug abuse. Final visual acuity strongly depends on the time needed for the correct diagnosis, the infectious agent and the selection of adequate treatment. Identification of the infectious agent by vitreous biopsy and blood cultures enables the ophthalmologist to choose a specific antibiotic treatment. Therapy consists of topical, intravitreal and systemic antibiotics or antimycotics often in combination with steroids and pars plana vitrectomy. As many of the patients with endogenous endophthalmitis are initially misdiagnosed (e. g. uveitis), it is important to consider this disease in the presence of suspicious symptoms.
- Published
- 2008
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.